Literature DB >> 35468191

Chronic Exposure to Waterpipe Smoke Elicits Immunomodulatory and Carcinogenic Effects in the Lung.

Maya Hassane1, Zahraa Rahal2, Nareg Karaoghlanian3, Jiexin Zhang4, Ansam Sinjab2, Justin W Wong5, Wei Lu2, Paul Scheet5, J Jack Lee4, Maria Gabriela Raso2, Luisa M Solis2, Junya Fujimoto2, Hassan Chami6, Alan L Shihadeh3, Humam Kadara2.   

Abstract

Effects of waterpipe smoking on lung pathobiology and carcinogenesis remain sparse despite the worldwide emergence of this tobacco vector. To address this gap, we investigated the effects of chronic waterpipe smoke (WPS) exposure on lung pathobiology, host immunity, and tumorigenesis using an experimental animal model that is prone to tobacco carcinogens and an exploratory observational analysis of human waterpipe smokers and nonsmokers. Mice exhibited elevated incidence of lung tumors following heavy WPS exposure (5 days/week for 20 weeks) compared to littermates with light WPS (once/week for 20 weeks) or control air. Lungs of mice exposed to heavy WPS showed augmented CD8+ and CD4+ T cell counts along with elevated protumor immune phenotypes including increased IL17A in T/B cells, PD-L1 on tumor and immune cells, and the proinflammatory cytokine IL1β in myeloid cells. RNA-sequencing (RNA-seq) analysis showed reduced antitumor immune gene signatures in animals exposed to heavy WPS relative to control air. We also performed RNA-seq analysis of airway epithelia from bronchial brushings of cancer-free waterpipe smokers and nonsmokers undergoing diagnostic bronchoscopy. Transcriptomes of normal airway cells in waterpipe smokers, relative to waterpipe nonsmokers, harbored gene programs that were associated with poor clinical outcomes in patients with lung adenocarcinoma, alluding to a WPS-associated molecular injury, like that established in response to cigarette smoking. Our findings support the notion that WPS exhibits carcinogenic effects and constitutes a possible risk factor for lung cancer as well as warrant future studies that can guide evidence-based policies for mitigating waterpipe smoking. PREVENTION RELEVANCE: Potential carcinogenic effects of waterpipe smoking are very poorly understood despite its emergence as a socially acceptable form of smoking. Our work highlights carcinogenic effects of waterpipe smoking in the lung and, thus, accentuate the need for inclusion of individuals with exclusive waterpipe smoking in prevention and smoking cessation studies. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35468191      PMCID: PMC9256796          DOI: 10.1158/1940-6207.CAPR-21-0610

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  48 in total

Review 1.  Waterpipe smoking: a review of pulmonary and health effects.

Authors:  Fares Darawshy; Ayman Abu Rmeileh; Rottem Kuint; Neville Berkman
Journal:  Eur Respir Rev       Date:  2021-05-11

2.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

Review 3.  The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll.

Authors:  Robert N Proctor
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

4.  IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.

Authors:  Mark Ayers; Jared Lunceford; Michael Nebozhyn; Erin Murphy; Andrey Loboda; David R Kaufman; Andrew Albright; Jonathan D Cheng; S Peter Kang; Veena Shankaran; Sarina A Piha-Paul; Jennifer Yearley; Tanguy Y Seiwert; Antoni Ribas; Terrill K McClanahan
Journal:  J Clin Invest       Date:  2017-06-26       Impact factor: 14.808

5.  Biomarkers of Secondhand Smoke Exposure in Waterpipe Tobacco Venue Employees in Istanbul, Moscow, and Cairo.

Authors:  Katherine A Moon; Ana M Rule; Hoda S Magid; Jacqueline M Ferguson; Jolie Susan; Zhuolu Sun; Christine Torrey; Salahaddin Abubaker; Vladimir Levshin; Asli Çarkoglu; Ghada Nasr Radwan; Maha El-Rabbat; Joanna E Cohen; Paul Strickland; Patrick N Breysse; Ana Navas-Acien
Journal:  Nicotine Tob Res       Date:  2018-03-06       Impact factor: 4.244

6.  Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma.

Authors:  Jacob Kantrowitz; Ansam Sinjab; Li Xu; Tina L McDowell; Smruthy Sivakumar; Wenhua Lang; Sayuri Nunomura-Nakamura; Junya Fukuoka; Georges Nemer; Nadine Darwiche; Hassan Chami; Arafat Tfayli; Ignacio I Wistuba; Paul Scheet; Junya Fujimoto; Avrum E Spira; Humam Kadara
Journal:  Cancer Prev Res (Phila)       Date:  2018-01-30

7.  Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.

Authors:  David F McDermott; Mahrukh A Huseni; Michael B Atkins; Robert J Motzer; Brian I Rini; Bernard Escudier; Lawrence Fong; Richard W Joseph; Sumanta K Pal; James A Reeves; Mario Sznol; John Hainsworth; W Kimryn Rathmell; Walter M Stadler; Thomas Hutson; Martin E Gore; Alain Ravaud; Sergio Bracarda; Cristina Suárez; Riccardo Danielli; Viktor Gruenwald; Toni K Choueiri; Dorothee Nickles; Suchit Jhunjhunwala; Elisabeth Piault-Louis; Alpa Thobhani; Jiaheng Qiu; Daniel S Chen; Priti S Hegde; Christina Schiff; Gregg D Fine; Thomas Powles
Journal:  Nat Med       Date:  2018-06-04       Impact factor: 53.440

8.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.

Authors:  Peng Jiang; Shengqing Gu; Deng Pan; Jingxin Fu; Avinash Sahu; Xihao Hu; Ziyi Li; Nicole Traugh; Xia Bu; Bo Li; Jun Liu; Gordon J Freeman; Myles A Brown; Kai W Wucherpfennig; X Shirley Liu
Journal:  Nat Med       Date:  2018-08-20       Impact factor: 53.440

Review 9.  Smoking and Lung Cancer: A Geo-Regional Perspective.

Authors:  Zahraa Rahal; Shaza El Nemr; Ansam Sinjab; Hassan Chami; Arafat Tfayli; Humam Kadara
Journal:  Front Oncol       Date:  2017-09-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.